Zobrazeno 1 - 10
of 447
pro vyhledávání: '"Jean-Luc Raoul"'
Autor:
Elodie Martin, Karine Le Malicot, Catherine Guérin-Charbonnel, François Bocquet, Olivier Bouché, Anthony Turpin, Thomas Aparicio, Jean-Louis Legoux, Laetitia Dahan, Julien Taieb, Côme Lepage, Louis-Marie Dourthe, Caroline Pétorin, Vincent Bourgeois, Jean-Luc Raoul, Valérie Seegers
Publikováno v:
Current Oncology, Vol 31, Iss 6, Pp 3513-3528 (2024)
In controlled phase II trials, major prognostic factors need to be well balanced between arms. The main procedures used are SPBR (Stratified Permuted Block Randomization) and minimization. First, we provide a systematic review of the treatment alloca
Externí odkaz:
https://doaj.org/article/1b66cb6abd0345388b47ec4d691cb925
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
Autor:
Ke Zhou, Marie Robert, Valérie Seegers, Audrey Blanc-Lapierre, Stéphane Savouroux, Frédéric Bigot, Jean-Sébastien Frenel, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Jean-Luc Raoul, Martine M Bellanger
Publikováno v:
PLoS ONE, Vol 19, Iss 5, p e0304556 (2024)
BackgroundLonger times between diagnosis and treatments of cancer patients have been estimated as effects of the COVID-19 pandemic. However, relatively few studies attempted to estimate actual delay to treatment at the patient level.ObjectiveTo asses
Externí odkaz:
https://doaj.org/article/dc5daa6a832b496198b0d922d82d61ff
Autor:
Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M. Bellanger, Jean-Luc Raoul
Publikováno v:
Cancers, Vol 15, Iss 19, p 4777 (2023)
In a multicenter prospective cohort of cancer patients (CP; n = 840) and healthcare workers (HCWs; n = 935) vaccinated against COVID-19, we noticed the following: i/after vaccination, 4.4% of HCWs and 5.8% of CP were infected; ii/no characteristic wa
Externí odkaz:
https://doaj.org/article/31f6812923e74345af095702e4b9ebf9
Autor:
Margaux Lelong, Jean‐Luc Raoul, Yann Touchefeu, Jean‐Marie Berthelot, Paul Arnolfo, Tamara Matysiak‐Budnik, Hélène Senellart
Publikováno v:
Clinical Case Reports, Vol 10, Iss 12, Pp n/a-n/a (2022)
Abstract This 38‐year‐old man has a familial BRCA2 mutation. He presented with skin erythema, polyarthritis, dactylitis, and febrile erythema nodosum; a biopsy of a liver metastase revealed acinar cell carcinoma of the pancreas. After FOLFIRINOX,
Externí odkaz:
https://doaj.org/article/7066e67ef7084323a455760a7d8742b4
Autor:
Manon Baverez, Emilie Thibaudeau, Vincent Libois, Olivier Kerdraon, Hélène Senellart, Jean-Luc Raoul
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 147-151 (2021)
We report the case of a 57-year-old woman who presented with local invasion of the anal canal by mucinous adenocarcinoma, the malignant transformation of a long-term preexisting retrorectal tailgut cyst. This progression is infrequent and justifies p
Externí odkaz:
https://doaj.org/article/4c2cd754912c4e70a5a998bd81338dd1
Transient Vision Loss – A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases
Autor:
Loic Ah-Thiane, Jean-Luc Raoul, Sandrine Hiret, Hélène Senellart, Frédéric Dumont, Judith Raimbourg
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 1, Pp 483-486 (2021)
Oxaliplatin, a platinum-based chemotherapeutic agent, is responsible for induced peripheral sensory neuropathy. Only a few cases of ophthalmologic toxicity have been reported. We report here two cases of sudden transient vision loss after oxaliplatin
Externí odkaz:
https://doaj.org/article/4b9377f097744fe4a1af090036a17c63
Autor:
Ke Zhou, Jean-Luc Raoul, Audrey Blanc-Lapierre, Valérie Seegers, Michèle Boisdron-Celle, Marianne Bourdon, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Martine M Bellanger, Frédéric Bigot
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 16 (2022)
Background: Cancer patients (CPs) are considered more vulnerable and as a high mortality group regarding COVID-19. In this analysis, we aimed to describe asymptomatic COVID (+) CPs and associated factors. Methods: We conducted a prospective study in
Externí odkaz:
https://doaj.org/article/c904ab906e364ff9a913c197daea705d
Publikováno v:
Cancers, Vol 14, Iss 23, p 5868 (2022)
The standard of care of first-line systemic therapy for advanced hepatocellular carcinoma (HCC) is currently changing with the results of the IMbrave150 trial which are demonstrating superiority of the atezolizumab-bevacizumab combination over sorafe
Externí odkaz:
https://doaj.org/article/bf0d775b3946485ba8567e298e840175
Autor:
Valérie Seegers, Guillaume Rousseau, Ke Zhou, Audrey Blanc-Lapierre, Frédéric Bigot, Hakim Mahammedi, Aurélien Lambert, Camille Moreau-Bachelard, Mario Campone, Thierry Conroy, Frédérique Penault-Llorca, Michèle Boisdron-Celle, Martine Bellanger, Jean-Luc Raoul
Publikováno v:
Cancers, Vol 14, Iss 22, p 5547 (2022)
In this prospective, real-life cohort study, we followed 523 cancer patients (CP) and 579 healthcare workers (HCW) from two cancer centers to evaluate the biological and clinical results of the COVID-19 vaccination campaign. Seventy percent of the CP
Externí odkaz:
https://doaj.org/article/6b9fb10e496745d1bbb78824ca0a0610
Autor:
Camille Moreau-Bachelard, Valentin Letailleur, Emmanuelle Bompas, Patrick Soulié, Julie Paul, Jean-Luc Raoul
Publikováno v:
Cancers, Vol 14, Iss 19, p 4721 (2022)
The absorption of pazopanib depends on gastric pH. PPIs are frequently prescribed for cancer patients to modify gastric acidity, decreasing pazopanib absorption. The aim of our study was, retrospectively, to investigate the impact of PPIs on the clin
Externí odkaz:
https://doaj.org/article/7ea9e73822b54b258115b948514b844f